Shares of Kaya Ltd were locked at 10% upper circuit on 4 July after the company announced its collaboration with Marico. 

The FMCG major, Marico, will handle sales and marketing of the company’s 75+ efficacious science-based personal care products that are outside of Kaya’s clinics. 

In its regulatory filing, the company said that the collaboration will leverage the capabilities and expertise of both the company, unlocking the untapped growth potential of the brand by increasing the presence and accessibility across market and channels. 

The company offers an extensive portfolio of dermatologist-recommended products that range from specialised solutions for acne, sun care, brightening, anti-aging, and hair care to daily essentials. These products are currently available across e-commerce marketplaces and 70+ Kaya Skin Clinics across the country. 

Until 31 March 2013, the Kaya Business operated as a subsidiary of Marico. After the demerger, Kaya and its subsidiaries managed the business.

Kaya’s operations primarily involve offering skin care services and products under the brand name Kaya, both in India and the Middle East.

At 3:30 pm, Kaya’s shares closed 10% higher at Rs 499.45 on NSE.